Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other financing activities (2024)

Historic Other financing activities for Arrowhead Pharmaceuticals (ARWR) over the last 6 years, with Q4 2024 value amounting to $5.0 million.

  • Arrowhead Pharmaceuticals' Other financing activities changed N/A to $5.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 5954.05%. This contributed to the annual value of $5.0 million for FY2025, which is 5954.05% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Other financing activities of $5.0 million as of Q4 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other financing activities peaked at $5.0 million during Q4 2024, and registered a low of $3.1 million during Q3 2024.